RVMD - Revolution Medicines, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Revolution Medicines, Inc.
IPO Date: February 13, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $43.05B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.22 | 2.89%
Avg Daily Range (30 D): $3.53 | 1.72%
Avg Daily Range (90 D): $3.92 | 2.10%
Institutional Daily Volume
Avg Daily Volume: 1.06M
Avg Daily Volume (30 D): 1.67M
Avg Daily Volume (90 D): 1.81M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 47
Avg Trade Size (Sh.) (90 D): 52
Institutional Trades
Total Institutional Trades: 9,880
Avg Institutional Trade: $4.14M
Avg Institutional Trade (30 D): $5.5M
Avg Institutional Trade (90 D): $6.19M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $13.01M
Avg Closing Trade (30 D): $66.3M
Avg Closing Trade (90 D): $69.13M
Avg Closing Volume: 212.64K
 
News
Sep 11, 2026 @ 3:29 PM
Amgen vs. Revolution Medicines: Which Healthcare S...
Source: Sara Appino
Sep 2, 2026 @ 9:50 PM
New England Journal of Medicine Publishes Phase 1/...
Source: Revolution Medicines, Inc.
Aug 28, 2026 @ 11:07 AM
Revolution Medicines Won FDA Approval One Month Af...
Source: Eric Volkman
Aug 26, 2026 @ 10:17 PM
Onco360® Has Been Selected as a National Pharma...
Source: Not Specified
Aug 26, 2026 @ 4:59 PM
U.S. FDA Approves Revolution Medicines’ RAS...
Source: Revolution Medicines, Inc.
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-8.85 $-3.06 $-2.29
Diluted EPS $-8.85 $-3.06 $-2.29
Revenue $M $M $M
Gross Profit
Net Income / Loss $-1768.29M $-644.37M $-453.82M
Operating Income / Loss $-1627.25M $-505.13M $-445.22M
Cost of Revenue
Net Cash Flow $413.94M $374.5M $57.19M
PE Ratio